4-(3-butoxy-4-methoxybenzyl)-2-imidazolidinone has been researched along with 1-hexadecyl-2-acetyl-glycero-3-phosphocholine in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Baker, R; Bruce, C; Kentroti, S; Lee, K; Vernadakis, A | 1 |
1 other study(ies) available for 4-(3-butoxy-4-methoxybenzyl)-2-imidazolidinone and 1-hexadecyl-2-acetyl-glycero-3-phosphocholine
Article | Year |
---|---|
Platelet-activating factor increases glutamine synthetase activity in early and late passage C-6 glioma cells.
Topics: 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone; Animals; Astrocytes; Bucladesine; Glioma; Glutamate-Ammonia Ligase; Indicators and Reagents; Neoplasm Proteins; Phenotype; Phosphodiesterase Inhibitors; Platelet Activating Factor; Rats; Tumor Cells, Cultured | 1991 |